The Impact of Long-Term Parenteral Nutrition on Physical Development and Bone Mineralization in Children with Chronic Intestinal Failure
Nutrients · 2025
DOI: 10.3390/nu17040611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Hanna Romanowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University, 71-2…. Hauptthemen laut MEDLINE: Intestinal Failure, Parenteral Nutrition, Bone Diseases, Metabolic, Child Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish Society of Clinical Nutrition for Children.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
This cross-sectional study aimed to assess growth, body weight, and bone mineralization and to identify predictors of metabolic bone disease (MBD) in children with chronic intestinal failure (CIF) on long-term parenteral nutrition (LPN).
Methods
Twenty-six children with CIF were evaluated on total parenteral nutrition (PN) for at least three years, and 60 healthy controls were assessed. Measurements included body weight, height, BMI, serum levels of 25-hydroxyvitamin D3 (25-OHD3), calcium (Ca), phosphorus (P), magnesium (Mg), and aluminum (Al), as well as urinary excretion of these elements. Dual-energy X-ray absorptiometry (DXA) and the mid-arm muscle area (MAMA) and mid-arm fat area (MAFA) of the CIF group were estimated.
Results
CIF children had significantly lower height, weight, and BMI Z-scores than controls (p < 0.001). While the median bone mineral density (BMD) Z-score was >−2, 34.7% had L1–L4 Z-scores ≤ −2. Urinary Ca and Al excretion were higher in LPN patients, positively correlating with serum 25-OHD3 levels (r = 0.48). Lower serum Ca, P, and Mg were observed in LPN patients (p < 0.001), and BMC L1–L4 correlated positively with MAMA, MAFA, and BMI.
Conclusions
The physical development of children who require long-term parenteral nutrition due to intestinal failure is poorer than that of healthy children. Although there are risk factors for bone mineralization disorders in children with intestinal failure, no clinical issues, such as pathological fractures, have been observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University, 71-252 Szczecin, Poland.
- Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
- Department of Pediatrics, Gastroenterology, Allergology and Nutrition, Medical University of Gdańsk, 80-803 Gdańsk, Poland.
ORCID-Profile: Hanna Romanowska, Janusz Książyk
Förderung
- Polish Society of Clinical Nutrition for Children
Zitieren
APA
Romanowska, H., Danko, M., Popińska, K., Żydak, J., Sibilska, M., Wielopolska, J., Bartoszewicz, K., Borkowska, A., Walczak, M., & Książyk, J. (2025). The Impact of Long-Term Parenteral Nutrition on Physical Development and Bone Mineralization in Children with Chronic Intestinal Failure. Nutrients. https://doi.org/10.3390/nu17040611
Vancouver
Romanowska H, Danko M, Popińska K, Żydak J, Sibilska M, Wielopolska J, et al. The Impact of Long-Term Parenteral Nutrition on Physical Development and Bone Mineralization in Children with Chronic Intestinal Failure. Nutrients. 2025. doi:10.3390/nu17040611
BibTeX
@article{Romanowska2025,
author = {Romanowska, Hanna and Danko, Mikołaj and Popińska, Katarzyna and Żydak, Joanna and Sibilska, Marta and Wielopolska, Joanna and Bartoszewicz, Klaudia and Borkowska, Anna and Walczak, Mieczysław and Książyk, Janusz},
title = {The Impact of Long-Term Parenteral Nutrition on Physical Development and Bone Mineralization in Children with Chronic Intestinal Failure},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17040611}
}
EUVIMED